#USA #Redwood City #Biohub #Protein Biology #ESMFold2

Biohub's Revolutionary World Model of Protein Biology

On May 27, 2026, Biohub announced a groundbreaking development in protein biology—a world model that serves as a scientific engine for predicting, designing, and discovering protein interactions across the tapestry of life. This innovative model, comprising ESMC, ESMFold2, and ESM Atlas, has the potential to accelerate the journey from understanding protein structures to crafting therapeutic agents.

The Essence of Proteins in Biological Functions

Proteins are the essential machinery behind countless biological functions, influencing everything from cellular communication to physiological responses. They are pivotal in medical advancements as targets for drug design. However, creating stable and functional proteins tailored for specific tasks within the human body has historically posed significant hurdles due to the complex nature of their interactions and structures.

Introducing ESMC and ESMFold2

Central to Biohub's model is ESMC, a state-of-the-art language model trained on an extensive dataset of 2.8 billion protein sequences from diverse life forms. This training enables the model to internalize key principles governing protein behavior, forming a foundational 'grammar' for protein biology. Following this, ESMFold2 emerges as the design engine that transforms ESMC representations into detailed, atomic-resolution 3D structures of biomolecular complexes.

One of the remarkable achievements of ESMFold2 is its ability to outperform existing models, such as AlphaFold 3, in predicting the binding poses of antibody-antigen complexes. By utilizing evolutionary information and enabling multiple predictions, ESMFold2's accuracy significantly improves when provided with enhanced computational resources.

Speeding Up Therapeutic Discovery

Traditionally, the journey to find viable therapeutic candidates spans several years, often taking three to four years to identify a suitable binder against a target. However, through ESMFold2, the initial stages of this process can now shift to computational methods, reducing the timeline to mere days. In recent studies, researchers employed ESMFold2 to design protein binders targeting five critical aspects of cancer and immunology, achieving hit rates between 15% and 88%—far surpassing conventional methods.

ESMFold2's prowess was demonstrated in laboratory experiments where designed binders not only exhibited substantial affinity for their targets but also restored T cell signaling in vitro, a significant step in potential therapeutic applications, especially in cancer treatment.

A Shared Scientific Ecosystem

Biohub’s mission is clear: to foster collaboration and innovation through open science. The company believes that by providing these powerful tools to researchers globally, they can catalyze the development of personalized medicines. This approach positions Biohub as a leader in bioengineering, empowering scientists to tackle diseases holistically and efficiently.

With the ESM Atlas, researchers can navigate a vast database containing 6.8 billion protein sequences and over 1.1 billion predicted structures. This immense resource offers insights into uncharted biological territories, potentially leading to new discoveries about diseases that have previously posed challenges due to poorly understood biology.

Conclusion

In essence, Biohub's release of its world model of protein biology marks a paradigm shift in biochemistry and therapeutic design. As open science gains traction, the collaboration between computational tools and biological research stands poised to reshape the landscape of medicine. By capitalizing on Biohub's innovative models, researchers can now expedite the path from discovery to application, establishing more effective treatment avenues for myriad diseases. As Dr. Priscilla Chan, Biohub Co-Founder, stated, "These tools bring us closer to personalized cures, tailored specifically to target the biology driving individual diseases."
Together, ESMC, ESMFold2, and ESM Atlas create a formidable ecosystem, emphasizing the importance of collaboration in the quest to understand and combat disease at its core.